Combinatorial immunotherapy strategies: most gods throw dice, but fate
Langue
en
Article de revue
Ce document a été publié dans
Annals of Oncology. 2019-11, vol. 30, n° 11, p. 1690-1691
Elsevier
Résumé en anglais
Immuno-oncology drugs (IODs) are considered as game-changing treatments in oncology, because diseases with once dismal prognosis such as metastatic melanoma or lung cancer now show 3-year survival rates in the 20-40% range. ...Lire la suite >